Can hand and face transplant patients ever ditch Anti-Rejection drugs?
NCT ID NCT02055521
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 27 times
Summary
This study looked for signs of immune tolerance in 18 people who received hand or face transplants at least one year earlier. Researchers tested blood and skin samples for markers that might show which patients could safely lower their anti-rejection medications. The goal is to reduce the long-term side effects of these drugs, which are currently needed for life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAND AND FACE ALLOTRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospices Civils de Lyon
Lyon, 69003, France
Conditions
Explore the condition pages connected to this study.